Atyr Pharma Stock Today
| LIFE Stock | USD 1.70 0.04 2.41% |
Performance0 of 100
| Odds Of DistressOver 54
|
ATyr Pharma is trading at 1.70 as of the 8th of May 2024, a 2.41% increase since the beginning of the trading day. The stock's lowest day price was 1.64. ATyr Pharma has 54 percent odds of going through some form of financial distress in the next two years and has generated negative returns to investors over the last 90 days. Equity ratings for aTyr Pharma are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 8th of February 2024 and ending today, the 8th of May 2024. Click here to learn more.
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company was incorporated in 2005 and is headquartered in San Diego, California. Atyr Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 69.01 M outstanding shares of which 383.05 K shares are now shorted by private and institutional investors with about 0.71 trading days to cover. More on aTyr Pharma
Moving together with ATyr Stock
| 0.62 | VAXX | Vaxxinity Financial Report 14th of May 2024 | PairCorr |
Moving against ATyr Stock
| 0.63 | VERU | Veru Inc Financial Report 9th of May 2024 | PairCorr |
| 0.49 | YS | YS Biopharma | PairCorr |
| 0.41 | DSGN | Design Therapeutics Trending | PairCorr |
Follow Valuation Odds of Bankruptcy
Financial Report 14th of May 2024
ATyr Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. ATyr Pharma's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding ATyr Pharma or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO President | MS MD |
| Old Name | LifeWatch AG |
| Business Concentration | Pharmaceutical Products, Biotechnology, Healthcare, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
aTyr Pharma (LIFE) is traded on NASDAQ Exchange in USA. It is located in 10240 Sorrento Valley Road, San Diego, CA, United States, 92121 and employs 56 people. ATyr Pharma is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 117.32 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate ATyr Pharma's market, we take the total number of its shares issued and multiply it by ATyr Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. aTyr Pharma conducts business under Biotechnology sector and is part of Health Care industry. The entity has 69.01 M outstanding shares of which 383.05 K shares are now shorted by private and institutional investors with about 0.71 trading days to cover.
aTyr Pharma currently holds about 88.55 M in cash with (33.22 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.09, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check ATyr Pharma Probability Of Bankruptcy
Ownership AllocationATyr Pharma holds a total of 69.01 Million outstanding shares. Over half of ATyr Pharma's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in ATyr Pharma. Please watch out for any change in the institutional holdings of aTyr Pharma as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check ATyr Ownership Details
ATyr Stock Price Odds Analysis
What are ATyr Pharma's target price odds to finish over the current price? Based on a normal probability distribution, the odds of ATyr Pharma jumping above the current price in 90 days from now is about 71.31%. The aTyr Pharma probability density function shows the probability of ATyr Pharma stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 1.0732. This indicates aTyr Pharma market returns are highly-sensitive to returns on the market. As the market goes up or down, ATyr Pharma is expected to follow. Additionally, aTyr Pharma has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of ATyr Pharma to move above the current price in 90 days from now is about 71.31 (This aTyr Pharma probability density function shows the probability of ATyr Stock to fall within a particular range of prices over 90 days) .
aTyr Pharma Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. ATyr Pharma market risk premium is the additional return an investor will receive from holding ATyr Pharma long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in ATyr Pharma. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although ATyr Pharma's alpha and beta are two of the key measurements used to evaluate ATyr Pharma's performance over the market, the standard measures of volatility play an important role as well.
| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.25) | |||
| Total Risk Alpha | (0.67) | |||
| Treynor Ratio | (0.16) |
ATyr Stock Against Markets
Picking the right benchmark for ATyr Pharma stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in ATyr Pharma stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for ATyr Pharma is critical whether you are bullish or bearish towards aTyr Pharma at a given time. Please also check how ATyr Pharma's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in ATyr Pharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Sectors Now
SectorsList of equity sectors categorizing publicly traded companies based on their primary business activities |
| All Next | Launch Module |
ATyr Pharma Corporate Management
Elected by the shareholders, the ATyr Pharma's board of directors comprises two types of representatives: ATyr Pharma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ATyr. The board's role is to monitor ATyr Pharma's management team and ensure that shareholders' interests are well served. ATyr Pharma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ATyr Pharma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Danielle Campbell | VP Resource | Profile | |
| XiangLei Yang | Founder | Profile | |
| Ying Buechler | Executive Manufacturing | Profile | |
| Jill Broadfoot | Chief Officer | Profile |
How to buy ATyr Stock?
Before investing in ATyr Pharma, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in ATyr Pharma. To buy ATyr Pharma stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of ATyr Pharma. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase ATyr Pharma stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located aTyr Pharma stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased aTyr Pharma stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as aTyr Pharma, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy ATyr Stock please use our How to Invest in ATyr Pharma guide.
Already Invested in aTyr Pharma?
The danger of trading aTyr Pharma is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of ATyr Pharma is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than ATyr Pharma. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile aTyr Pharma is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether aTyr Pharma is a strong investment it is important to analyze ATyr Pharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ATyr Pharma's future performance. For an informed investment choice regarding ATyr Stock, refer to the following important reports: Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in aTyr Pharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census. For information on how to trade ATyr Stock refer to our How to Trade ATyr Stock guide.Note that the aTyr Pharma information on this page should be used as a complementary analysis to other ATyr Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Complementary Tools for ATyr Stock analysis
When running ATyr Pharma's price analysis, check to measure ATyr Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ATyr Pharma is operating at the current time. Most of ATyr Pharma's value examination focuses on studying past and present price action to predict the probability of ATyr Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ATyr Pharma's price. Additionally, you may evaluate how the addition of ATyr Pharma to your portfolios can decrease your overall portfolio volatility.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |
Is ATyr Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ATyr Pharma. If investors know ATyr will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ATyr Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of aTyr Pharma is measured differently than its book value, which is the value of ATyr that is recorded on the company's balance sheet. Investors also form their own opinion of ATyr Pharma's value that differs from its market value or its book value, called intrinsic value, which is ATyr Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ATyr Pharma's market value can be influenced by many factors that don't directly affect ATyr Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ATyr Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if ATyr Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ATyr Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.